Pfizer sues Johnson & Johnson, the Twitter 'mafia' in health and fitness tech, a brain implant for restoring sight and other interesting reads from this week.

General

The Republicans next week will make one final attempt to kill President Obama’s signature reforms. Link

Synthetic opioids have become the star performers in China’s pharma market. Link

Backed by the Gates Foundation, Africa to get state-of-art HIV drugs for $75 a year. Link

Pfizer sues Johnson & Johnson, alleging "anticompetitive" dealmaking. Link

Alnylam's RNAi drug succeeds in a key study. Link

FDA clears biosimilars, but buying them isn’t so easy for patients. Link

Too few antibiotics in pipeline to tackle the global drug-resistance crisis. Link

A neglected family of killer viruses. Link

Digital Health

Meet the Twitter 'mafia' in health and fitness tech. Link

Big pharma jumps on the blockchain wagon. Link

BERG + Department Of Defense + Artificial Intelligence = New prostate cancer test. Link

Why a Silicon Valley approach can’t work for health tech. Link

Research

New studies show 100% HIV protection in monkeys via antibody combos. Link

A brain implant for restoring sight will enter clinical trials. Link

The mitochondria as a new potential window to impending cardiac arrest. Link

Perspective and Opinions

The questions about gene editing that need answers. Link

Even at $500k, gene therapy could be a bargain for some diseases. Link

How biotechnology will soon give almost anyone the power to destroy humanity. Link

Interesting

Teens are becoming adults later than they used to. Link

The biggest threat to the world? It’s not disease or Trump or Kim Jong-un. Link

Genome sequencing for sick newborns may be the norm in the future. Link

Startups of the Week